title: Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
abstract: Rabbit corneas were injected intrastromally with Pseudomonas aeruginosa. Sixteen hours after injection, the rabbits were divided randomly into four treatment groups (3 rabbits/6 eyes per group: 1, ciprofloxacin and prednisolone; 2, ciprofloxacin only; 3, prednisolone only; 4, untreated. Ocular signs of inflammation were graded in a masked fashion by slit lamp examination before injection and 16 and 27 hours after injection. Slit lamp examination scores were significantly lower in eyes receiving ciprofloxacin and prednisolone or prednisolone alone, compared with scores in untreated eyes. Slit lamp examination scores were not significantly lower in eyes receiving ciprofloxacin alone, compared with untreated controls. The numbers of viable bacteria in the corneas treated with ciprofloxacin and in the corneas treated with ciprofloxacin and prednisolone were similar and were significantly less (P less than 0.0001) than those in untreated corneas, indicating that the presence of the steroid did not interfere with the bactericidal action of ciprofloxacin.
authors.affiliation: Department of Microbiology, Immunology, and Parasitology, LSU Eye Center, New Orleans 70112.
authors.forename: J A
authors.initials: JA
authors.lastname: Hobden
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Callaghan
authors.forename: J M
authors.initials: JM
authors.lastname: Hill
authors.forename: M
authors.initials: M
authors.lastname: Hagenah
authors.forename: M S
authors.initials: MS
authors.lastname: Insler
authors.forename: J J
authors.initials: JJ
authors.lastname: Reidy
mesh_terms: D000287:Administration, Topical; D000818:Animals; D002939:Ciprofloxacin / Q000627:therapeutic use*; D015169:Colony Count, Microbial; D003319:Corneal Stroma / Q000382:microbiology; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000473:pathology; D007634:Keratitis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000473:pathology; D011550:Pseudomonas aeruginosa / Q000254:growth & development; D011817:Rabbits; D011897:Random Allocation
chemical_list: D002939:Ciprofloxacin; D011239:Prednisolone